| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |